Rebody Health Opens Physician-Reviewed NAD+ Injections Nationwide

“Rebody Health opens its physician-reviewed NAD+ injection program to adults nationwide, pairing an existing telehealth model for weight-loss and hormone care with at-home energy therapy that ships only after clinician review.”
Rebody Health expands nationwide access to physician-reviewed NAD+ injections, using the same clinician-review model already applied to its testosterone and weight-loss care.

NEW YORK – 22 September, 2026 – Rebody Health, a telehealth platform offering online prescriptions and home delivery for testosterone support, NAD+ energy therapy, peptides, and growth hormone and longevity treatments, today announced nationwide access to its physician-reviewed NAD+ injection program for adults across the United States. The expansion extends the platform’s existing weight-loss and hormone care model to at-home energy and cellular health support, using the same intake-and-clinician-review process already in place for testosterone and GLP-1 patients. NAD+ injections ship directly to a patient’s home once a licensed clinician confirms the prescription is appropriate.

Interest in NAD+ therapy has grown alongside broader demand for at-home hormone and longevity care, as adults look for energy and recovery support without scheduling an in-person infusion appointment. Rebody Health’s approach keeps that demand inside a licensed clinical framework rather than an unregulated supplement purchase: patients complete an online intake, a clinician reviews history and labs, and NAD+ injections for energy and mental clarity are prescribed only when medically appropriate. The model mirrors how the platform already handles testosterone and weight-loss prescriptions, rather than treating NAD+ as a separate, lower-oversight product line.

A Rebody Health spokesperson said the company built the NAD+ program on the same review standard as its hormone and weight-loss lines because patients increasingly ask for one clinician relationship instead of several disconnected vendors. “People come to us already on a testosterone or GLP-1 plan and ask if they can add NAD+ without starting over with a new provider,” the spokesperson said. “Nationwide access means the same clinician review, the same pricing clarity, and the same shipping process, just applied to a new treatment.”

Physician review before every prescription

Every NAD+ injection prescription on the Rebody Health platform starts with an online intake form covering symptoms, medical history, and current medications. A licensed clinician reviews the submission, and patients who want lab context before that review can complete an at-home hormone testing kit ahead of the consultation. NAD+ injections are shipped only after a clinician confirms the prescription is appropriate for that patient — the treatment does not ship on request alone.

NAD+ joins an existing at-home hormone and longevity line

NAD+ injections now sit alongside testosterone support, peptides, and growth hormone and longevity treatments already offered through Rebody Health’s telehealth model. The company applies the same clinician-review and home-delivery structure across all four categories, so a patient managing testosterone therapy can add NAD+ energy support through the same account and the same review process rather than opening a separate relationship with another provider. That consistency is the operational detail behind the nationwide rollout: the review standard does not change by treatment type.

Nationwide delivery with ongoing clinical follow-up

Rebody Health ships prescribed NAD+ injections to patients’ homes across the United States, with pricing shown up front before a patient commits to a plan. Clinicians remain available through the platform for follow-up questions after a prescription ships, consistent with how the company handles testosterone and weight-loss patients who need dose or plan adjustments over time.

A second Rebody Health spokesperson statement addressed why the company chose to expand NAD+ access now rather than launch it as a stand-alone product. “NAD+ works better as part of a full picture of someone’s hormone and energy status, not as an isolated purchase,” the spokesperson said. “Running it through the same intake and clinician review we use for testosterone and weight-loss patients keeps the oversight consistent instead of treating NAD+ like a supplement aisle item.”

About Rebody Health

Rebody Health is a telehealth platform offering online prescriptions and home delivery for testosterone support, NAD+ energy therapy, peptides, and growth hormone and longevity treatments for adults across the United States. The platform pairs an online intake process with licensed clinician review before any prescription ships, covering medically supervised weight-loss care, hormone therapy, and NAD+ energy support through a single account. Patients can complete at-home hormone testing ahead of a telehealth consultation, and prescriptions for testosterone, NAD+, peptides, and growth hormone and longevity treatments ship directly to their homes once a clinician confirms they are appropriate. More information is available at rebodyhealth.com.

Media Contact
Company Name: Rebody Health
Contact Person: Press
Email: Send Email
Phone: 650-535-8019
Address:95 3rd St
City: San Francisco
State: CA
Country: United States
Website: https://rebodyhealth.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rebody Health Opens Physician-Reviewed NAD+ Injections Nationwide

Media gallery